Frontiers in Immunology (Mar 2018)

Evaluation of Antigen-Conjugated Fluorescent Beads to Identify Antigen-Specific B Cells

  • Isabel Correa,
  • Isabel Correa,
  • Kristina M. Ilieva,
  • Kristina M. Ilieva,
  • Kristina M. Ilieva,
  • Silvia Crescioli,
  • Silvia Crescioli,
  • Sara Lombardi,
  • Mariangela Figini,
  • Anthony Cheung,
  • Anthony Cheung,
  • James F. Spicer,
  • Andrew N. J. Tutt,
  • Andrew N. J. Tutt,
  • Frank O. Nestle,
  • Frank O. Nestle,
  • Frank O. Nestle,
  • Panagiotis Karagiannis,
  • Panagiotis Karagiannis,
  • Panagiotis Karagiannis,
  • Katie E. Lacy,
  • Sophia N. Karagiannis,
  • Sophia N. Karagiannis,
  • Sophia N. Karagiannis

DOI
https://doi.org/10.3389/fimmu.2018.00493
Journal volume & issue
Vol. 9

Abstract

Read online

Selection of single antigen-specific B cells to identify their expressed antibodies is of considerable interest for evaluating human immune responses. Here, we present a method to identify single antibody-expressing cells using antigen-conjugated fluorescent beads. To establish this, we selected Folate Receptor alpha (FRα) as a model antigen and a mouse B cell line, expressing both the soluble and the membrane-bound forms of a human/mouse chimeric antibody (MOv18 IgG1) specific for FRα, as test antibody-expressing cells. Beads were conjugated to FRα using streptavidin/avidin-biotin bridges and used to select single cells expressing the membrane-bound form of anti-FRα. Bead-bound cells were single cell-sorted and processed for single cell RNA retrotranscription and PCR to isolate antibody heavy and light chain variable regions. Variable regions were then cloned and expressed as human IgG1/k antibodies. Like the original clone, engineered antibodies from single cells recognized native FRα. To evaluate whether antigen-coated beads could identify specific antibody-expressing cells in mixed immune cell populations, human peripheral blood mononuclear cells (PBMCs) were spiked with test antibody-expressing cells. Antigen-specific cells could comprise up to 75% of cells selected with antigen-conjugated beads when the frequency of the antigen-positive cells was 1:100 or higher. In PBMC pools, beads conjugated to recombinant antigens FRα and HER2 bound antigen-specific anti-FRα MOv18 and anti-HER2 Trastuzumab antibody-expressing cells, respectively. From melanoma patient-derived B cells selected with melanoma cell line-derived protein-coated fluorescent beads, we generated a monoclonal antibody that recognized melanoma antigen-coated beads. This approach may be further developed to facilitate analysis of B cells and their antibody profiles at the single cell level and to help unravel humoral immune repertoires.

Keywords